GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Name | miRBASE accession |
---|---|
hsa-miR-27a-3p
|
MIMAT0000084 |
hsa-miR-27b-3p
|
MIMAT0000419 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chrX_+_64708615 | 15.23 |
ENST00000338957.4
ENST00000423889.3 |
ZC3H12B
|
zinc finger CCCH-type containing 12B |
chr20_+_10199468 | 11.04 |
ENST00000254976.2
ENST00000304886.2 |
SNAP25
|
synaptosomal-associated protein, 25kDa |
chr10_-_21786179 | 9.38 |
ENST00000377113.5
|
CASC10
|
cancer susceptibility candidate 10 |
chr16_-_4292071 | 7.37 |
ENST00000399609.3
|
SRL
|
sarcalumenin |
chr8_+_80523321 | 7.34 |
ENST00000518111.1
|
STMN2
|
stathmin-like 2 |
chr16_-_70719925 | 6.73 |
ENST00000338779.6
|
MTSS1L
|
metastasis suppressor 1-like |
chr12_-_105478339 | 6.61 |
ENST00000424857.2
ENST00000258494.9 |
ALDH1L2
|
aldehyde dehydrogenase 1 family, member L2 |
chr12_+_79258547 | 6.13 |
ENST00000457153.2
|
SYT1
|
synaptotagmin I |
chr2_-_100939195 | 6.07 |
ENST00000393437.3
|
LONRF2
|
LON peptidase N-terminal domain and ring finger 2 |
chr10_+_104474207 | 6.02 |
ENST00000602831.1
ENST00000369893.5 |
SFXN2
|
sideroflexin 2 |
chrX_-_54384425 | 5.32 |
ENST00000375169.3
ENST00000354646.2 |
WNK3
|
WNK lysine deficient protein kinase 3 |
chr5_+_71403061 | 5.06 |
ENST00000512974.1
ENST00000296755.7 |
MAP1B
|
microtubule-associated protein 1B |
chr6_-_46293378 | 5.05 |
ENST00000330430.6
|
RCAN2
|
regulator of calcineurin 2 |
chr17_+_43971643 | 5.05 |
ENST00000344290.5
ENST00000262410.5 ENST00000351559.5 ENST00000340799.5 ENST00000535772.1 ENST00000347967.5 |
MAPT
|
microtubule-associated protein tau |
chr5_-_115910630 | 4.67 |
ENST00000343348.6
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
chr2_-_71454185 | 4.57 |
ENST00000244221.8
|
PAIP2B
|
poly(A) binding protein interacting protein 2B |
chr4_-_153457197 | 4.34 |
ENST00000281708.4
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
chr2_+_242641442 | 4.29 |
ENST00000313552.6
ENST00000406941.1 |
ING5
|
inhibitor of growth family, member 5 |
chr14_-_81687197 | 4.25 |
ENST00000553612.1
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa |
chr6_-_119399895 | 4.24 |
ENST00000338891.7
|
FAM184A
|
family with sequence similarity 184, member A |
chr17_+_30813576 | 4.11 |
ENST00000313401.3
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
chr3_+_11034403 | 4.11 |
ENST00000287766.4
ENST00000425938.1 |
SLC6A1
|
solute carrier family 6 (neurotransmitter transporter), member 1 |
chr7_-_103629963 | 4.09 |
ENST00000428762.1
ENST00000343529.5 ENST00000424685.2 |
RELN
|
reelin |
chr3_-_179169330 | 4.05 |
ENST00000232564.3
|
GNB4
|
guanine nucleotide binding protein (G protein), beta polypeptide 4 |
chr15_+_29131103 | 4.05 |
ENST00000558402.1
ENST00000558330.1 |
APBA2
|
amyloid beta (A4) precursor protein-binding, family A, member 2 |
chr22_-_39239987 | 3.91 |
ENST00000333039.2
|
NPTXR
|
neuronal pentraxin receptor |
chr10_-_124768300 | 3.88 |
ENST00000368886.5
|
IKZF5
|
IKAROS family zinc finger 5 (Pegasus) |
chr6_+_126112001 | 3.86 |
ENST00000392477.2
|
NCOA7
|
nuclear receptor coactivator 7 |
chr19_+_7968728 | 3.84 |
ENST00000397981.3
ENST00000545011.1 ENST00000397983.3 ENST00000397979.3 |
MAP2K7
|
mitogen-activated protein kinase kinase 7 |
chrX_-_67653614 | 3.79 |
ENST00000355520.5
|
OPHN1
|
oligophrenin 1 |
chr16_-_75498553 | 3.76 |
ENST00000569276.1
ENST00000357613.4 ENST00000561878.1 ENST00000566980.1 ENST00000567194.1 |
TMEM170A
RP11-77K12.1
|
transmembrane protein 170A Uncharacterized protein |
chr11_-_123525289 | 3.75 |
ENST00000392770.2
ENST00000299333.3 ENST00000530277.1 |
SCN3B
|
sodium channel, voltage-gated, type III, beta subunit |
chr20_+_34700333 | 3.61 |
ENST00000441639.1
|
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
chr5_-_111754948 | 3.56 |
ENST00000261486.5
|
EPB41L4A
|
erythrocyte membrane protein band 4.1 like 4A |
chr12_-_42538657 | 3.50 |
ENST00000398675.3
|
GXYLT1
|
glucoside xylosyltransferase 1 |
chr11_-_18656028 | 3.48 |
ENST00000336349.5
|
SPTY2D1
|
SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae) |
chr8_+_1922024 | 3.47 |
ENST00000320248.3
|
KBTBD11
|
kelch repeat and BTB (POZ) domain containing 11 |
chr2_-_206950781 | 3.45 |
ENST00000403263.1
|
INO80D
|
INO80 complex subunit D |
chr5_-_93447333 | 3.45 |
ENST00000395965.3
ENST00000505869.1 ENST00000509163.1 |
FAM172A
|
family with sequence similarity 172, member A |
chr4_+_113970772 | 3.35 |
ENST00000504454.1
ENST00000394537.3 ENST00000357077.4 ENST00000264366.6 |
ANK2
|
ankyrin 2, neuronal |
chrX_-_40594755 | 3.31 |
ENST00000324817.1
|
MED14
|
mediator complex subunit 14 |
chr2_-_37193606 | 3.31 |
ENST00000379213.2
ENST00000263918.4 |
STRN
|
striatin, calmodulin binding protein |
chr22_-_44258360 | 3.25 |
ENST00000330884.4
ENST00000249130.5 |
SULT4A1
|
sulfotransferase family 4A, member 1 |
chr5_-_179780312 | 3.25 |
ENST00000253778.8
|
GFPT2
|
glutamine-fructose-6-phosphate transaminase 2 |
chr16_+_1756162 | 3.23 |
ENST00000250894.4
ENST00000356010.5 |
MAPK8IP3
|
mitogen-activated protein kinase 8 interacting protein 3 |
chr7_+_77325738 | 3.18 |
ENST00000334955.8
|
RSBN1L
|
round spermatid basic protein 1-like |
chr19_-_49576198 | 3.17 |
ENST00000221444.1
|
KCNA7
|
potassium voltage-gated channel, shaker-related subfamily, member 7 |
chr22_-_28197486 | 3.12 |
ENST00000302326.4
|
MN1
|
meningioma (disrupted in balanced translocation) 1 |
chrX_+_23352133 | 3.12 |
ENST00000379361.4
|
PTCHD1
|
patched domain containing 1 |
chr1_-_200992827 | 3.10 |
ENST00000332129.2
ENST00000422435.2 |
KIF21B
|
kinesin family member 21B |
chr19_+_18794470 | 3.05 |
ENST00000321949.8
ENST00000338797.6 |
CRTC1
|
CREB regulated transcription coactivator 1 |
chr10_-_62149433 | 2.96 |
ENST00000280772.2
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G) |
chr3_-_56502375 | 2.95 |
ENST00000288221.6
|
ERC2
|
ELKS/RAB6-interacting/CAST family member 2 |
chr2_+_24163281 | 2.94 |
ENST00000309033.4
|
UBXN2A
|
UBX domain protein 2A |
chr11_-_108369101 | 2.94 |
ENST00000323468.5
|
KDELC2
|
KDEL (Lys-Asp-Glu-Leu) containing 2 |
chrX_+_56259316 | 2.89 |
ENST00000468660.1
|
KLF8
|
Kruppel-like factor 8 |
chr11_+_14665263 | 2.89 |
ENST00000282096.4
|
PDE3B
|
phosphodiesterase 3B, cGMP-inhibited |
chr11_+_118401706 | 2.86 |
ENST00000411589.2
ENST00000442938.2 ENST00000359862.4 |
TMEM25
|
transmembrane protein 25 |
chr4_+_85504075 | 2.86 |
ENST00000295887.5
|
CDS1
|
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1 |
chr14_-_100070363 | 2.85 |
ENST00000380243.4
|
CCDC85C
|
coiled-coil domain containing 85C |
chr12_-_124457371 | 2.83 |
ENST00000238156.3
ENST00000545037.1 |
CCDC92
|
coiled-coil domain containing 92 |
chr12_+_4918342 | 2.82 |
ENST00000280684.3
ENST00000433855.1 |
KCNA6
|
potassium voltage-gated channel, shaker-related subfamily, member 6 |
chr4_-_53525406 | 2.82 |
ENST00000451218.2
ENST00000441222.3 |
USP46
|
ubiquitin specific peptidase 46 |
chr7_-_31380502 | 2.78 |
ENST00000297142.3
|
NEUROD6
|
neuronal differentiation 6 |
chr2_-_50574856 | 2.75 |
ENST00000342183.5
|
NRXN1
|
neurexin 1 |
chr2_-_201936302 | 2.74 |
ENST00000453765.1
ENST00000452799.1 ENST00000446678.1 ENST00000418596.3 |
FAM126B
|
family with sequence similarity 126, member B |
chr5_+_112043186 | 2.74 |
ENST00000509732.1
ENST00000457016.1 ENST00000507379.1 |
APC
|
adenomatous polyposis coli |
chr9_-_91793675 | 2.71 |
ENST00000375835.4
ENST00000375830.1 |
SHC3
|
SHC (Src homology 2 domain containing) transforming protein 3 |
chr5_+_65018017 | 2.68 |
ENST00000380985.5
ENST00000502464.1 |
NLN
|
neurolysin (metallopeptidase M3 family) |
chr12_-_49110613 | 2.61 |
ENST00000261900.3
|
CCNT1
|
cyclin T1 |
chr3_-_178790057 | 2.60 |
ENST00000311417.2
|
ZMAT3
|
zinc finger, matrin-type 3 |
chr13_-_67804445 | 2.60 |
ENST00000456367.1
ENST00000377861.3 ENST00000544246.1 |
PCDH9
|
protocadherin 9 |
chr8_-_98290087 | 2.45 |
ENST00000322128.3
|
TSPYL5
|
TSPY-like 5 |
chr11_-_117186946 | 2.44 |
ENST00000313005.6
ENST00000528053.1 |
BACE1
|
beta-site APP-cleaving enzyme 1 |
chr1_-_149889382 | 2.44 |
ENST00000369145.1
ENST00000369146.3 |
SV2A
|
synaptic vesicle glycoprotein 2A |
chr11_-_45687128 | 2.44 |
ENST00000308064.2
|
CHST1
|
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 |
chr3_+_36421826 | 2.41 |
ENST00000273183.3
|
STAC
|
SH3 and cysteine rich domain |
chr12_+_8234807 | 2.40 |
ENST00000339754.5
|
NECAP1
|
NECAP endocytosis associated 1 |
chr10_+_60272814 | 2.39 |
ENST00000373886.3
|
BICC1
|
bicaudal C homolog 1 (Drosophila) |
chr8_-_10588010 | 2.39 |
ENST00000304501.1
|
SOX7
|
SRY (sex determining region Y)-box 7 |
chr20_+_49348081 | 2.38 |
ENST00000371610.2
|
PARD6B
|
par-6 family cell polarity regulator beta |
chrX_+_122993827 | 2.33 |
ENST00000371199.3
|
XIAP
|
X-linked inhibitor of apoptosis |
chr11_-_74109422 | 2.33 |
ENST00000298198.4
|
PGM2L1
|
phosphoglucomutase 2-like 1 |
chr5_-_132073210 | 2.31 |
ENST00000378735.1
ENST00000378746.4 |
KIF3A
|
kinesin family member 3A |
chr18_+_54318616 | 2.30 |
ENST00000254442.3
|
WDR7
|
WD repeat domain 7 |
chr6_+_30524663 | 2.29 |
ENST00000376560.3
|
PRR3
|
proline rich 3 |
chr9_-_136857403 | 2.28 |
ENST00000406606.3
ENST00000371850.3 |
VAV2
|
vav 2 guanine nucleotide exchange factor |
chr6_-_99873145 | 2.27 |
ENST00000369239.5
ENST00000438806.1 |
PNISR
|
PNN-interacting serine/arginine-rich protein |
chr9_-_23821273 | 2.24 |
ENST00000380110.4
|
ELAVL2
|
ELAV like neuron-specific RNA binding protein 2 |
chr2_+_203879568 | 2.21 |
ENST00000449802.1
|
NBEAL1
|
neurobeachin-like 1 |
chr11_+_121322832 | 2.20 |
ENST00000260197.7
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing |
chr5_+_172483347 | 2.19 |
ENST00000522692.1
ENST00000296953.2 ENST00000540014.1 ENST00000520420.1 |
CREBRF
|
CREB3 regulatory factor |
chr17_+_25799008 | 2.16 |
ENST00000583370.1
ENST00000398988.3 ENST00000268763.6 |
KSR1
|
kinase suppressor of ras 1 |
chr20_-_41818373 | 2.14 |
ENST00000373187.1
ENST00000356100.2 ENST00000373184.1 ENST00000373190.1 |
PTPRT
|
protein tyrosine phosphatase, receptor type, T |
chr17_-_58603568 | 2.14 |
ENST00000083182.3
|
APPBP2
|
amyloid beta precursor protein (cytoplasmic tail) binding protein 2 |
chr16_-_68482440 | 2.13 |
ENST00000219334.5
|
SMPD3
|
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) |
chr5_-_57756087 | 2.12 |
ENST00000274289.3
|
PLK2
|
polo-like kinase 2 |
chr1_-_160001737 | 2.11 |
ENST00000368090.2
|
PIGM
|
phosphatidylinositol glycan anchor biosynthesis, class M |
chr3_+_139654018 | 2.11 |
ENST00000458420.3
|
CLSTN2
|
calsyntenin 2 |
chr21_+_33245548 | 2.08 |
ENST00000270112.2
|
HUNK
|
hormonally up-regulated Neu-associated kinase |
chr14_+_99947715 | 2.06 |
ENST00000389879.5
ENST00000557441.1 ENST00000555049.1 ENST00000555842.1 |
CCNK
|
cyclin K |
chr16_-_65155833 | 2.05 |
ENST00000566827.1
ENST00000394156.3 ENST00000562998.1 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
chr5_-_43313574 | 2.05 |
ENST00000325110.6
ENST00000433297.2 |
HMGCS1
|
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
chr8_-_94753229 | 2.05 |
ENST00000518597.1
ENST00000399300.2 ENST00000517700.1 |
RBM12B
|
RNA binding motif protein 12B |
chr16_+_23847339 | 2.05 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
chr4_+_47033345 | 2.04 |
ENST00000295454.3
|
GABRB1
|
gamma-aminobutyric acid (GABA) A receptor, beta 1 |
chr1_-_19229248 | 2.04 |
ENST00000375341.3
|
ALDH4A1
|
aldehyde dehydrogenase 4 family, member A1 |
chr1_-_154474589 | 2.03 |
ENST00000304760.2
|
SHE
|
Src homology 2 domain containing E |
chr14_+_85996471 | 2.02 |
ENST00000330753.4
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2 |
chr20_-_48532019 | 2.02 |
ENST00000289431.5
|
SPATA2
|
spermatogenesis associated 2 |
chr7_-_108096822 | 2.02 |
ENST00000379028.3
ENST00000413765.2 ENST00000379022.4 |
NRCAM
|
neuronal cell adhesion molecule |
chr5_-_95297678 | 2.01 |
ENST00000237853.4
|
ELL2
|
elongation factor, RNA polymerase II, 2 |
chr1_+_70876891 | 2.01 |
ENST00000411986.2
|
CTH
|
cystathionase (cystathionine gamma-lyase) |
chr10_-_81205373 | 2.00 |
ENST00000372336.3
|
ZCCHC24
|
zinc finger, CCHC domain containing 24 |
chr4_+_140374961 | 1.99 |
ENST00000305626.5
|
RAB33B
|
RAB33B, member RAS oncogene family |
chr3_+_14989076 | 1.98 |
ENST00000413118.1
ENST00000425241.1 |
NR2C2
|
nuclear receptor subfamily 2, group C, member 2 |
chr17_+_47572647 | 1.97 |
ENST00000172229.3
|
NGFR
|
nerve growth factor receptor |
chr7_-_105029329 | 1.96 |
ENST00000393651.3
ENST00000460391.1 |
SRPK2
|
SRSF protein kinase 2 |
chr6_-_39197226 | 1.96 |
ENST00000359534.3
|
KCNK5
|
potassium channel, subfamily K, member 5 |
chrX_+_16804544 | 1.95 |
ENST00000380122.5
ENST00000398155.4 |
TXLNG
|
taxilin gamma |
chr8_-_127570603 | 1.95 |
ENST00000304916.3
|
FAM84B
|
family with sequence similarity 84, member B |
chr12_-_54673871 | 1.95 |
ENST00000209875.4
|
CBX5
|
chromobox homolog 5 |
chr6_+_41606176 | 1.94 |
ENST00000441667.1
ENST00000230321.6 ENST00000373050.4 ENST00000446650.1 ENST00000435476.1 |
MDFI
|
MyoD family inhibitor |
chr4_-_90229142 | 1.92 |
ENST00000609438.1
|
GPRIN3
|
GPRIN family member 3 |
chr10_-_102279586 | 1.92 |
ENST00000370345.3
ENST00000451524.1 ENST00000370329.5 |
SEC31B
|
SEC31 homolog B (S. cerevisiae) |
chr13_+_24734844 | 1.91 |
ENST00000382108.3
|
SPATA13
|
spermatogenesis associated 13 |
chr17_+_54911444 | 1.91 |
ENST00000284061.3
ENST00000572810.1 |
DGKE
|
diacylglycerol kinase, epsilon 64kDa |
chr6_+_391739 | 1.91 |
ENST00000380956.4
|
IRF4
|
interferon regulatory factor 4 |
chr19_+_41222998 | 1.89 |
ENST00000263370.2
|
ITPKC
|
inositol-trisphosphate 3-kinase C |
chr10_+_111767720 | 1.87 |
ENST00000356080.4
ENST00000277900.8 |
ADD3
|
adducin 3 (gamma) |
chr19_-_16653325 | 1.86 |
ENST00000546361.2
|
CHERP
|
calcium homeostasis endoplasmic reticulum protein |
chr1_+_184356188 | 1.82 |
ENST00000235307.6
|
C1orf21
|
chromosome 1 open reading frame 21 |
chr16_+_11762270 | 1.82 |
ENST00000329565.5
|
SNN
|
stannin |
chr20_+_48599506 | 1.81 |
ENST00000244050.2
|
SNAI1
|
snail family zinc finger 1 |
chr19_-_13617247 | 1.81 |
ENST00000573710.2
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
chr5_-_132948216 | 1.79 |
ENST00000265342.7
|
FSTL4
|
follistatin-like 4 |
chr5_-_132299313 | 1.79 |
ENST00000265343.5
|
AFF4
|
AF4/FMR2 family, member 4 |
chr7_+_90225796 | 1.79 |
ENST00000380050.3
|
CDK14
|
cyclin-dependent kinase 14 |
chr11_-_73309228 | 1.76 |
ENST00000356467.4
ENST00000064778.4 |
FAM168A
|
family with sequence similarity 168, member A |
chr6_+_136172820 | 1.75 |
ENST00000308191.6
|
PDE7B
|
phosphodiesterase 7B |
chr2_+_5832799 | 1.74 |
ENST00000322002.3
|
SOX11
|
SRY (sex determining region Y)-box 11 |
chr11_+_58939965 | 1.71 |
ENST00000227451.3
|
DTX4
|
deltex homolog 4 (Drosophila) |
chr7_-_79082867 | 1.70 |
ENST00000419488.1
ENST00000354212.4 |
MAGI2
|
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
chr2_-_38303218 | 1.68 |
ENST00000407341.1
ENST00000260630.3 |
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1 |
chr10_-_15762124 | 1.66 |
ENST00000378076.3
|
ITGA8
|
integrin, alpha 8 |
chr10_+_63661053 | 1.66 |
ENST00000279873.7
|
ARID5B
|
AT rich interactive domain 5B (MRF1-like) |
chr10_+_104678032 | 1.66 |
ENST00000369878.4
ENST00000369875.3 |
CNNM2
|
cyclin M2 |
chr1_+_220701456 | 1.66 |
ENST00000366918.4
ENST00000402574.1 |
MARK1
|
MAP/microtubule affinity-regulating kinase 1 |
chr2_-_9143786 | 1.64 |
ENST00000462696.1
ENST00000305997.3 |
MBOAT2
|
membrane bound O-acyltransferase domain containing 2 |
chr4_+_20255123 | 1.62 |
ENST00000504154.1
ENST00000273739.5 |
SLIT2
|
slit homolog 2 (Drosophila) |
chr12_+_70760056 | 1.60 |
ENST00000258111.4
|
KCNMB4
|
potassium large conductance calcium-activated channel, subfamily M, beta member 4 |
chr9_+_103790991 | 1.60 |
ENST00000374874.3
|
LPPR1
|
Lipid phosphate phosphatase-related protein type 1 |
chr12_+_103981044 | 1.60 |
ENST00000388887.2
|
STAB2
|
stabilin 2 |
chr9_-_135819987 | 1.57 |
ENST00000298552.3
ENST00000403810.1 |
TSC1
|
tuberous sclerosis 1 |
chr9_+_34958254 | 1.57 |
ENST00000242315.3
|
KIAA1045
|
KIAA1045 |
chr6_-_8064567 | 1.56 |
ENST00000543936.1
ENST00000397457.2 |
BLOC1S5
|
biogenesis of lysosomal organelles complex-1, subunit 5, muted |
chr10_-_119806085 | 1.55 |
ENST00000355624.3
|
RAB11FIP2
|
RAB11 family interacting protein 2 (class I) |
chr10_-_90712520 | 1.54 |
ENST00000224784.6
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta |
chr19_+_1286097 | 1.52 |
ENST00000215368.2
|
EFNA2
|
ephrin-A2 |
chr10_-_70287231 | 1.52 |
ENST00000609923.1
|
SLC25A16
|
solute carrier family 25 (mitochondrial carrier; Graves disease autoantigen), member 16 |
chr1_+_65613217 | 1.52 |
ENST00000545314.1
|
AK4
|
adenylate kinase 4 |
chr11_-_31839488 | 1.51 |
ENST00000419022.1
ENST00000379132.3 ENST00000379129.2 |
PAX6
|
paired box 6 |
chr2_+_46524537 | 1.51 |
ENST00000263734.3
|
EPAS1
|
endothelial PAS domain protein 1 |
chr12_+_132195617 | 1.49 |
ENST00000261674.4
ENST00000535236.1 ENST00000541286.1 |
SFSWAP
|
splicing factor, suppressor of white-apricot homolog (Drosophila) |
chr2_-_27718052 | 1.48 |
ENST00000264703.3
|
FNDC4
|
fibronectin type III domain containing 4 |
chr5_+_52285144 | 1.44 |
ENST00000296585.5
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |
chr1_-_41131326 | 1.43 |
ENST00000372684.3
|
RIMS3
|
regulating synaptic membrane exocytosis 3 |
chr5_-_121413974 | 1.42 |
ENST00000231004.4
|
LOX
|
lysyl oxidase |
chr11_-_86666427 | 1.41 |
ENST00000531380.1
|
FZD4
|
frizzled family receptor 4 |
chr2_-_25142708 | 1.39 |
ENST00000260600.5
ENST00000435135.1 |
ADCY3
|
adenylate cyclase 3 |
chr17_-_53499310 | 1.39 |
ENST00000262065.3
|
MMD
|
monocyte to macrophage differentiation-associated |
chr5_-_160279207 | 1.38 |
ENST00000327245.5
|
ATP10B
|
ATPase, class V, type 10B |
chr7_-_27183263 | 1.38 |
ENST00000222726.3
|
HOXA5
|
homeobox A5 |
chr17_-_3461092 | 1.36 |
ENST00000301365.4
ENST00000572519.1 |
TRPV3
|
transient receptor potential cation channel, subfamily V, member 3 |
chr1_-_36022979 | 1.34 |
ENST00000469892.1
ENST00000325722.3 |
KIAA0319L
|
KIAA0319-like |
chr15_+_33010175 | 1.34 |
ENST00000300177.4
ENST00000560677.1 ENST00000560830.1 |
GREM1
|
gremlin 1, DAN family BMP antagonist |
chr5_-_111093406 | 1.33 |
ENST00000379671.3
|
NREP
|
neuronal regeneration related protein |
chr14_+_56585048 | 1.32 |
ENST00000267460.4
|
PELI2
|
pellino E3 ubiquitin protein ligase family member 2 |
chr1_+_35734562 | 1.31 |
ENST00000314607.6
ENST00000373297.2 |
ZMYM4
|
zinc finger, MYM-type 4 |
chr4_+_71587669 | 1.30 |
ENST00000381006.3
ENST00000226328.4 |
RUFY3
|
RUN and FYVE domain containing 3 |
chr11_+_33278811 | 1.30 |
ENST00000303296.4
ENST00000379016.3 |
HIPK3
|
homeodomain interacting protein kinase 3 |
chr8_-_42698433 | 1.30 |
ENST00000345117.2
ENST00000254250.3 |
THAP1
|
THAP domain containing, apoptosis associated protein 1 |
chr1_-_21671968 | 1.30 |
ENST00000415912.2
|
ECE1
|
endothelin converting enzyme 1 |
chr8_-_93115445 | 1.29 |
ENST00000523629.1
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr8_+_85097110 | 1.29 |
ENST00000517638.1
ENST00000522647.1 |
RALYL
|
RALY RNA binding protein-like |
chr10_+_127408263 | 1.28 |
ENST00000337623.3
|
C10orf137
|
erythroid differentiation regulatory factor 1 |
chr1_-_184723942 | 1.28 |
ENST00000318130.8
|
EDEM3
|
ER degradation enhancer, mannosidase alpha-like 3 |
chr16_+_2587998 | 1.27 |
ENST00000441549.3
ENST00000268673.7 |
PDPK1
|
3-phosphoinositide dependent protein kinase-1 |
chr5_+_135468516 | 1.27 |
ENST00000507118.1
ENST00000511116.1 ENST00000545279.1 ENST00000545620.1 |
SMAD5
|
SMAD family member 5 |
chrX_+_102631248 | 1.26 |
ENST00000361298.4
ENST00000372645.3 ENST00000372635.1 |
NGFRAP1
|
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr1_-_57045228 | 1.26 |
ENST00000371250.3
|
PPAP2B
|
phosphatidic acid phosphatase type 2B |
chr6_-_41747595 | 1.25 |
ENST00000373018.3
|
FRS3
|
fibroblast growth factor receptor substrate 3 |
chr17_+_29421900 | 1.25 |
ENST00000358273.4
ENST00000356175.3 |
NF1
|
neurofibromin 1 |
chr9_+_112403088 | 1.25 |
ENST00000448454.2
|
PALM2
|
paralemmin 2 |
chr16_+_66878814 | 1.25 |
ENST00000394069.3
|
CA7
|
carbonic anhydrase VII |
chr15_-_73661605 | 1.24 |
ENST00000261917.3
|
HCN4
|
hyperpolarization activated cyclic nucleotide-gated potassium channel 4 |
chr3_+_119187785 | 1.23 |
ENST00000295588.4
ENST00000476573.1 |
POGLUT1
|
protein O-glucosyltransferase 1 |
chr10_-_97321112 | 1.23 |
ENST00000607232.1
ENST00000371227.4 ENST00000371249.2 ENST00000371247.2 ENST00000371246.2 ENST00000393949.1 ENST00000353505.5 ENST00000347291.4 |
SORBS1
|
sorbin and SH3 domain containing 1 |
chr4_+_55095264 | 1.21 |
ENST00000257290.5
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide |
chr2_-_235405679 | 1.21 |
ENST00000390645.2
|
ARL4C
|
ADP-ribosylation factor-like 4C |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.6 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
2.0 | 6.1 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
1.9 | 9.7 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
1.8 | 7.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.4 | 4.1 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
1.1 | 3.4 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
1.0 | 4.1 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
1.0 | 4.1 | GO:0097477 | NMDA glutamate receptor clustering(GO:0097114) spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.0 | 3.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
1.0 | 5.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
1.0 | 3.9 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.9 | 2.7 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.9 | 4.3 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.9 | 2.6 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.8 | 1.7 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
0.8 | 2.3 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.8 | 3.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.7 | 3.0 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.7 | 2.2 | GO:1905246 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
0.7 | 2.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.7 | 2.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.7 | 2.0 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.6 | 1.9 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.6 | 3.1 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.6 | 1.9 | GO:0060023 | soft palate development(GO:0060023) |
0.6 | 4.9 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.6 | 1.8 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.6 | 0.6 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.5 | 1.6 | GO:0021966 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) corticospinal neuron axon guidance(GO:0021966) regulation of negative chemotaxis(GO:0050923) negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
0.5 | 2.6 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.5 | 2.0 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
0.5 | 2.0 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.5 | 5.0 | GO:0086015 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) |
0.5 | 2.4 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.5 | 1.4 | GO:0008355 | olfactory learning(GO:0008355) |
0.4 | 1.3 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.4 | 0.9 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.4 | 2.9 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.4 | 1.2 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.4 | 0.8 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.4 | 1.2 | GO:0072276 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.4 | 2.0 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.4 | 2.0 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.4 | 1.1 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) |
0.4 | 1.8 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.3 | 1.0 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
0.3 | 2.7 | GO:0097118 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.3 | 2.0 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.3 | 1.0 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.3 | 1.3 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.3 | 2.9 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.3 | 1.6 | GO:0051029 | rRNA transport(GO:0051029) |
0.3 | 2.8 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.3 | 2.8 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 2.7 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.3 | 1.5 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.3 | 2.0 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.3 | 2.6 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.3 | 1.1 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.3 | 2.0 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
0.3 | 1.1 | GO:1990535 | transformation of host cell by virus(GO:0019087) neuron projection maintenance(GO:1990535) |
0.3 | 0.5 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.3 | 1.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.3 | 1.5 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.3 | 1.3 | GO:0097466 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.3 | 0.8 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.3 | 1.5 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.3 | 4.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 1.2 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.2 | 3.9 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.2 | 3.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 1.0 | GO:1902617 | response to fluoride(GO:1902617) |
0.2 | 1.4 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.2 | 2.1 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 5.2 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.2 | 1.8 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 0.4 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.2 | 2.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.8 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 2.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 0.4 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.2 | 0.6 | GO:0021764 | amygdala development(GO:0021764) |
0.2 | 2.0 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
0.2 | 0.4 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) negative regulation of interferon-alpha production(GO:0032687) |
0.2 | 1.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 1.4 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.2 | 1.0 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.2 | 2.0 | GO:0009642 | response to light intensity(GO:0009642) |
0.2 | 2.9 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.2 | 4.9 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 1.6 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.2 | 1.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.2 | 0.7 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 0.8 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.2 | 1.0 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.2 | 2.0 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.2 | 1.8 | GO:0060828 | regulation of canonical Wnt signaling pathway(GO:0060828) |
0.2 | 0.3 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.2 | 1.8 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.2 | 0.6 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.2 | 0.9 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.2 | 0.8 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) histone H2A phosphorylation(GO:1990164) |
0.2 | 0.5 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 1.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.2 | 6.7 | GO:0097178 | ruffle assembly(GO:0097178) |
0.2 | 0.9 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.1 | 1.0 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 1.2 | GO:0019563 | glycerol catabolic process(GO:0019563) |
0.1 | 2.2 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.9 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.1 | 0.4 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.9 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.1 | 1.3 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.1 | 0.9 | GO:0044254 | angiotensin catabolic process in blood(GO:0002005) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) |
0.1 | 0.4 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 0.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.9 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.1 | 1.0 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.1 | 0.6 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.1 | 0.6 | GO:1904141 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
0.1 | 4.3 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 2.2 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 2.1 | GO:1903543 | positive regulation of exosomal secretion(GO:1903543) |
0.1 | 0.2 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 0.4 | GO:0090107 | aminophospholipid transport(GO:0015917) regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.1 | 0.8 | GO:1902915 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 3.3 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 2.9 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 2.1 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 | 1.7 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.1 | 0.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.9 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 3.6 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.3 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.1 | 1.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 2.7 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 3.8 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 1.0 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.1 | 0.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.1 | 3.8 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 2.1 | GO:0021772 | olfactory bulb development(GO:0021772) |
0.1 | 0.7 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.1 | 8.0 | GO:0042795 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 3.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.9 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.1 | 0.3 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
0.1 | 1.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 3.2 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 1.6 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.4 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
0.1 | 0.5 | GO:0035624 | receptor transactivation(GO:0035624) |
0.1 | 0.4 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 2.2 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.3 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.1 | 0.1 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 1.0 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.1 | 0.6 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.1 | 0.6 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.9 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.9 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.4 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 2.8 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) |
0.1 | 0.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 1.6 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.3 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 1.5 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 | 0.6 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.5 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.1 | 0.6 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.1 | 0.6 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 1.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 0.4 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 1.6 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.1 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.5 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 2.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 4.1 | GO:0021762 | substantia nigra development(GO:0021762) |
0.1 | 0.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.9 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.6 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.5 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.8 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 2.0 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.1 | 0.9 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.5 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 5.3 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.1 | 0.9 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.1 | 1.8 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.4 | GO:0097490 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.1 | 1.3 | GO:0009299 | mRNA transcription(GO:0009299) |
0.0 | 1.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.7 | GO:0016575 | histone deacetylation(GO:0016575) |
0.0 | 0.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.6 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.0 | 0.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 1.6 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 2.1 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 1.2 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 2.5 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 0.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.0 | GO:2001038 | regulation of cellular response to drug(GO:2001038) |
0.0 | 0.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.9 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 2.5 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 6.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.8 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.0 | 0.4 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.4 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 1.3 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.8 | GO:0044070 | regulation of anion transport(GO:0044070) |
0.0 | 0.3 | GO:0099624 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.0 | 0.3 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 1.2 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.0 | 0.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.4 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.6 | GO:0001764 | neuron migration(GO:0001764) |
0.0 | 2.9 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.3 | GO:0051963 | regulation of synapse assembly(GO:0051963) positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.2 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.0 | 1.8 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.6 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 1.9 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.1 | GO:1900122 | B-1 B cell differentiation(GO:0001923) positive regulation of receptor binding(GO:1900122) |
0.0 | 0.3 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 | 0.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.4 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.0 | 0.2 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.0 | 1.5 | GO:0051058 | negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 | 4.5 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.7 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.0 | 1.8 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.0 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 2.9 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.3 | GO:0001935 | endothelial cell proliferation(GO:0001935) |
0.0 | 0.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.7 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.3 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.7 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.9 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 0.1 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
0.0 | 0.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.8 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 3.0 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.0 | 0.7 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 4.3 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.0 | 3.7 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.0 | 0.2 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 1.4 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
0.0 | 0.3 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.7 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.0 | 0.1 | GO:0071799 | adenosine metabolic process(GO:0046085) response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.2 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.2 | GO:0050673 | epithelial cell proliferation(GO:0050673) |
0.0 | 0.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.3 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.2 | GO:0061025 | membrane fusion(GO:0061025) |
0.0 | 0.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.1 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.0 | 0.5 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 11.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.2 | 6.1 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
1.0 | 4.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.0 | 5.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.7 | 2.1 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.7 | 5.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.7 | 7.4 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.7 | 3.3 | GO:0070847 | core mediator complex(GO:0070847) |
0.6 | 4.3 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.6 | 1.8 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.6 | 2.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.6 | 1.7 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
0.5 | 1.4 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.4 | 4.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.4 | 1.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.4 | 1.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 5.8 | GO:0043194 | axon initial segment(GO:0043194) |
0.3 | 0.3 | GO:0044305 | calyx of Held(GO:0044305) |
0.3 | 2.6 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.3 | 1.3 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.3 | 2.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 1.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 3.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.2 | 2.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.2 | 1.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 2.7 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 0.7 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.2 | 1.7 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 0.6 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 2.9 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 0.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 0.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 0.9 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 0.5 | GO:0031213 | RSF complex(GO:0031213) |
0.2 | 0.9 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.2 | 8.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 0.7 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.2 | 1.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 0.8 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.1 | 2.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 2.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 1.9 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.4 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 2.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.1 | 0.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 1.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 6.9 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.6 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.6 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 3.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.6 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 9.1 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.1 | 3.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 2.2 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.1 | 0.7 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 3.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 2.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 11.7 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 1.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 3.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 6.0 | GO:0005814 | centriole(GO:0005814) |
0.1 | 3.5 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 1.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 2.4 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 2.6 | GO:0030120 | vesicle coat(GO:0030120) |
0.0 | 4.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 6.6 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.7 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 1.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.1 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.0 | 2.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 1.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 4.1 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.4 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 4.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 1.8 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.6 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 7.5 | GO:0030424 | axon(GO:0030424) |
0.0 | 3.8 | GO:0070160 | occluding junction(GO:0070160) |
0.0 | 0.4 | GO:0031985 | Golgi cisterna(GO:0031985) Golgi cisterna membrane(GO:0032580) |
0.0 | 0.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 2.9 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 2.4 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 1.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 2.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.3 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.7 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 2.7 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.9 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 7.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 1.2 | GO:0034702 | ion channel complex(GO:0034702) |
0.0 | 2.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.6 | GO:0005844 | polysome(GO:0005844) |
0.0 | 2.0 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.6 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
1.4 | 4.1 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
1.4 | 4.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.3 | 5.0 | GO:0099609 | microtubule lateral binding(GO:0099609) |
1.2 | 6.1 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
1.2 | 3.5 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
1.0 | 2.9 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.9 | 4.7 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.8 | 5.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.8 | 2.4 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.8 | 3.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.7 | 4.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.7 | 2.0 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
0.6 | 1.7 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.5 | 2.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.5 | 5.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.4 | 5.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.4 | 11.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.4 | 1.3 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.4 | 1.2 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.4 | 1.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 2.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.4 | 1.1 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
0.4 | 1.5 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.4 | 3.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 1.1 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.3 | 2.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 2.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 3.5 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.3 | 1.9 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.3 | 1.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.3 | 0.9 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.3 | 0.9 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.3 | 5.7 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.3 | 2.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.3 | 0.9 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.3 | 1.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.3 | 1.8 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.3 | 2.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 1.4 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 2.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.2 | 4.6 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 2.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 1.5 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.2 | 0.6 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.2 | 0.8 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.2 | 3.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 2.0 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 0.6 | GO:0050405 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
0.2 | 2.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 0.6 | GO:0017129 | triglyceride binding(GO:0017129) |
0.2 | 3.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 4.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 1.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.7 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.2 | 8.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 2.2 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.2 | 1.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 8.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 2.0 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 0.9 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.1 | 0.6 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 3.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.4 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.1 | 3.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 1.1 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 4.8 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 2.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 3.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 2.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.4 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.1 | 1.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 1.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 1.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.9 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 7.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 2.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 1.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 2.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 7.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 2.0 | GO:0016646 | aldehyde dehydrogenase (NAD) activity(GO:0004029) oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 0.3 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.1 | 1.7 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 1.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 1.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 1.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.4 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 2.8 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 0.6 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.1 | 10.1 | GO:0004519 | endonuclease activity(GO:0004519) |
0.1 | 2.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.3 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.1 | 1.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 4.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 1.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 5.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.6 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 1.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 2.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 1.2 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 1.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.2 | GO:0046934 | phosphatidylinositol 3-kinase activity(GO:0035004) phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 0.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 1.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 1.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 2.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.3 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.1 | 0.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 1.1 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 1.0 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.1 | 0.8 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 3.5 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 2.4 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.3 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.3 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 1.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 5.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.8 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.4 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 3.3 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 1.9 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.3 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.0 | 0.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 1.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.8 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.4 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 1.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 2.2 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.6 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 2.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 4.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.2 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.7 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 0.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 0.9 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 4.5 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 1.6 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.1 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.0 | 0.1 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 3.6 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.7 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 1.5 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 1.3 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.8 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
0.0 | 0.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.8 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.9 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.3 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.0 | 0.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.4 | 21.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.4 | 1.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 2.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 0.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 7.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 3.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 1.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 2.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 4.3 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 2.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 4.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 3.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 3.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 2.1 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 4.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 0.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 1.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.9 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 1.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 1.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 1.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 1.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 1.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 4.3 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 3.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 2.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 2.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 1.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 5.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 1.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.3 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.3 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 1.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 17.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.4 | 0.9 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.3 | 8.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 5.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.2 | 4.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 3.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 2.0 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.2 | 3.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 4.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 2.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 5.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 1.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 2.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 5.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 6.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 4.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 3.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 2.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 1.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 2.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 1.4 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 2.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 2.1 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 1.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 8.0 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.1 | 0.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 1.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 4.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 1.7 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 2.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 2.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.6 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 0.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 2.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 2.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 2.4 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.1 | 2.0 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 1.7 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.1 | 2.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 1.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 1.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 2.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 1.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.8 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 1.0 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.6 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 1.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 1.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 1.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.8 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 0.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 1.4 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 1.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 1.0 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 1.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |